Literature DB >> 10782395

Low correlation of serology with detection of Chlamydia trachomatis by ligase chain reaction and antigen EIA.

H F Rabenau1, E Köhler, M Peters, H W Doerr, B Weber.   

Abstract

The aim of the present study was to evaluate the diagnostic accuracy of serology by using new assays for the detection of genus and species-specific IgG, IgM, IgA and secretory IgA antibody in female sex workers. Cervical swabs and first void urine (FVU) from 314 female sex workers were submitted to nucleic acid amplification by ligase chain reaction (LCx, Abbott). Concomittantly, blood samples were tested for the presence of IgG, IgM and IgA antibodies using a genus-specific assay (rELISA, Medac) and species-specific test (SeroCT, Orgenics). Chlamydia trachomatis infection was detected in a total of 30 (9.6%) female sex workers by LCR. With rELISA, seroprevalences for IgG, IgM, and IgA antibody to Chlamydia were 88.9%, 19.1% and 62.7%, respectively. IgG and IgA antibody prevalences against C. trachomatis (SeroCT) were 65.0% and 23.9%, respectively. In comparison to the positive LCR results obtained from cervical swab and/or FVU, the sensitivity of rELISA for Chlamydia IgG, IgA and IgM detection was 93.3%, 83.3% and 16.7%, respectively. With SeroCT, the sensitivity for C. trachomatis-specific IgG and IgA detection was 86.7% and 33.3%, respectively. The specificities of both serologic tests in comparison to LCR were very low. In conclusion, the correlation of serology with active C. trachomatis infection of the lower genital tract is very low. According to our results, serologic testing for Chlamydia can exclude active infection of the lower genital tract with a high reliability (> or = 95%). However, detection of C. trachomatis can only be reliably achieved by nucleic acid amplification assays.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782395     DOI: 10.1007/s150100050054

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Correlation of Chlamydia and Chlamydophila spp. IgG and IgM antibodies by microimmunofluorescence with antigen detection methods.

Authors:  Rosemary C She; Ryan Welch; Andrew R Wilson; David Davis; Christine M Litwin
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

2.  Comprehensive Molecular Serology of Human Chlamydia trachomatis Infections by Peptide Enzyme-Linked Immunosorbent Assays.

Authors:  K Shamsur Rahman; Toni Darville; Ali N Russell; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; De'Ashia E Lee; Bernhard Kaltenboeck
Journal:  mSphere       Date:  2018-08-01       Impact factor: 4.389

3.  Mixed Chlamydia trachomatis Peptide Antigens Provide a Specific and Sensitive Single-Well Colorimetric Enzyme-Linked Immunosorbent Assay for Detection of Human Anti-C. trachomatis Antibodies.

Authors:  K Shamsur Rahman; Toni Darville; Harold C Wiesenfeld; Sharon L Hillier; Bernhard Kaltenboeck
Journal:  mSphere       Date:  2018-11-07       Impact factor: 4.389

4.  Multi-peptide ELISAs overcome cross-reactivity and inadequate sensitivity of conventional Chlamydia pneumoniae serology.

Authors:  Kh Shamsur Rahman; Bernhard Kaltenboeck
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

Review 5.  Chlamydia trachomatis as a Current Health Problem: Challenges and Opportunities.

Authors:  Rafaela Rodrigues; Carlos Sousa; Nuno Vale
Journal:  Diagnostics (Basel)       Date:  2022-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.